NVAX

Novavax Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 9/10
  • Value↑ 9/10
Novavax sales and earnings growth
NVAX Growth
Great
  • Revenue Y/Y↑ 64.69%
  • EPS Y/Y↑ 321.14%
  • FCF Y/Y↓ -146.34%
Novavax gross and profit margin trends
NVAX Profitability
Great
  • Gross margin ↑ 93.50%
  • EPS margin↑ 39.20%
  • ROIC 5Y↑ 615.44%
Novavax net debt vs free cash flow
NVAX Risk
Great
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 20.6

Novavax stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗